Science Market Update
Seven researchers from the University of California, San Francisco have received “high-risk, high-reward” grants for biomedical research.Read More
Tags: CA, University of California San Francisco, Medical Research, cancer research, California, Biomedical Reearch, San Francisco, SFVS, Research Funding, UCSF, UC San Francisco, NIH funding, Southwest Region, Mission Bay, UCSF Mission Bay, 2016, BioResearch Product Faire™
Scientists from UC San Francisco and Oregon Health & Science University (OHSU) have teamed up to tackle acute lymphoblastic leukemia (ALL), a blood cancer that typically affects children from two to five years old.Read More
Tags: CA, Leukemia, Oregon Health and Science University, cancer research, Oregon, California, Pediatric Cancer Research, 2015, San Francisco, SFVS, BioResearch Product Faire Event, OR, UCSF, OHSU, Portland, UC San Francisco, Biotechnology Vendor Showcase Event
Already the nation’s leading university for medical research, UCSF continues to expand thanks to a generous and recent donation.Read More
The UC San Francisco Medical Center is home to some of nation’s best doctors, industry-leading bio-researchers, and most recently, an angel. UCSF is proudly unveiling a new outpatient medical building- thanks to a $40 million gift from “angel investor” and philanthropist Ron Conway and his family.Read More
Sugar-sweetened soda consumption might promote disease independently from its role in obesity, according to UC San Francisco researchers who found in a new study that drinking sugary drinks was associated with cell aging.Read More
Tags: California, 2015, San Diego, UCDMC, San Francisco, UCSD, UC San Diego, UCSF, Sacramento, UC San Francisco, UC Davis - Medical Center, Northern California BioResearch, San Francisco at Mission Bay, San Francisco Bay Area
There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines.Read More
Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East
The three-year grant will enable a group of UCSF researchers to continue their development of the SMART diaphragm, a wireless device that can detect preterm labor onset sooner and more easily than current methods.
The University of California, San Francisco has been actively working on partnerships with several large Asian organizations to accelerate validation and commercialization of promising new technologies for health and disease solutions in 2014.